{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Pediatric+Infection&page=2", "query": { "condition": "Pediatric Infection", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Pediatric+Infection&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-25T03:30:25.323Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05544019", "title": "Study of SGR-1505 in Mature B-Cell Neoplasms", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Mature B-Cell Neoplasm", "Non Hodgkin Lymphoma", "DLBCL", "Waldenstrom Macroglobulinemia", "MALT Lymphoma", "Follicular Lymphoma", "Pediatric-Type Follicular Lymphoma", "IRF4 Gene Rearrangement", "EBV-Positive DLBCL, Nos", "Burkitt Lymphoma", "Plasmablastic Lymphoma", "High-grade B-cell Lymphoma", "Primary Cutaneous Follicle Center Lymphoma", "Primary Effusion Lymphoma", "Mantle Cell Lymphoma", "DLBCL Germinal Center B-Cell Type", "Primary Mediastinal Large B Cell Lymphoma", "T-Cell/Histiocyte Rich Lymphoma", "ALK-Positive Large B-Cell Lymphoma", "Primary Cutaneous Diffuse Large B-Cell Lymphoma", "Splenic Marginal Zone Lymphoma", "Chronic Lymphocytic Leukemia", "Nodal Marginal Zone Lymphoma", "HHV8-Positive DLBCL, Nos", "Lymphoplasmacytic Lymphoma", "Duodenal-Type Follicular Lymphoma" ], "interventions": [ { "name": "SGR-1505", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Schrödinger, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 98, "start_date": "2023-04-10", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 16, "location_summary": "Gilbert, Arizona • Newark, Delaware • Pompano Beach, Florida + 13 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Newark", "state": "Delaware" }, { "city": "Pompano Beach", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Hackensack", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05544019" }, { "nct_id": "NCT01263600", "title": "Hepatitis B Research Network Pediatric Cohort Study (HBRN)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatitis B" ], "interventions": [], "intervention_types": [], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Months to 17 Years" }, "enrollment_count": 462, "start_date": "2010-12", "completion_date": "2021-06-09", "has_results": false, "last_update_posted_date": "2022-05-31", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 6, "location_summary": "San Francisco, California • Baltimore, Maryland • Minneapolis, Minnesota + 3 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01263600" }, { "nct_id": "NCT06921993", "title": "Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pneumonia Childhood", "Pneumonia", "Lung Ultrasound", "Antibiotic Stewardship" ], "interventions": [ { "name": "LUNG ULTRASOUND", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Meyer Children's Hospital IRCCS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "10 Years", "sex": "ALL", "summary": "3 Years to 10 Years" }, "enrollment_count": 659, "start_date": "2025-04-24", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-04-03", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 4, "location_summary": "San Diego, California • New Haven, Connecticut • New York, New York + 1 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New York", "state": "New York" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06921993" }, { "nct_id": "NCT02466867", "title": "An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tinea Corporis" ], "interventions": [ { "name": "Naftin® Cream, 2% (younger pediatric cohort)", "type": "DRUG" }, { "name": "Naftin® Cream, 2% (older pediatric cohort)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 27, "start_date": "2014-01", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 1, "location_summary": "College Station, Texas", "locations": [ { "city": "College Station", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02466867" }, { "nct_id": "NCT01701063", "title": "An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "Telaprevir", "type": "DRUG" }, { "name": "Peginterferon alfa-2b", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "3 Years to 17 Years" }, "enrollment_count": 42, "start_date": "2013-01", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-07-20", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 13, "location_summary": "Phoenix, Arizona • San Francisco, California • Denver, Colorado + 10 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01701063" }, { "nct_id": "NCT00002118", "title": "An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Zalcitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "11 Years", "sex": "ALL", "summary": "3 Months to 11 Years" }, "enrollment_count": 600, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 1, "location_summary": "Nutley, New Jersey", "locations": [ { "city": "Nutley", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002118" }, { "nct_id": "NCT04892160", "title": "Distracting Through Procedural Pain and Distress", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Illness", "Hematologic Malignancy", "Bone Marrow Transplant Infection", "Oncology", "Sickle Cell Disease" ], "interventions": [ { "name": "Guided Imagery", "type": "OTHER" }, { "name": "Virtual Reality", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "8 Years to 25 Years" }, "enrollment_count": 67, "start_date": "2018-02-15", "completion_date": "2019-04-29", "has_results": false, "last_update_posted_date": "2021-05-19", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 2, "location_summary": "Milwaukee, Wisconsin • Wauwatosa, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" }, { "city": "Wauwatosa", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04892160" }, { "nct_id": "NCT05608993", "title": "RELAX: Reducing Length of Antibiotics for Children With Ear Infections", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Otitis Media", "Pediatric Infectious Disease", "Ear Infection" ], "interventions": [ { "name": "High Intensity Intervention", "type": "OTHER" }, { "name": "Low Intensity Intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Intermountain Health Care, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 500, "start_date": "2024-04-01", "completion_date": "2027-10", "has_results": false, "last_update_posted_date": "2025-08-17", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05608993" }, { "nct_id": "NCT02568189", "title": "Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and Dehydration", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sepsis", "Gastroenteritis", "Dehydration" ], "interventions": [ { "name": "SonoSite Maxx Series Ultrasound System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 112, "start_date": "2015-10-01", "completion_date": "2016-12-31", "has_results": true, "last_update_posted_date": "2024-06-13", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02568189" }, { "nct_id": "NCT00237055", "title": "Infectious Agents in Pediatric Crohn's", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Crohn's Disease", "Inflammatory Bowel Disease" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Months to 18 Years" }, "enrollment_count": 500, "start_date": "2004-08", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2010-03-18", "last_synced_at": "2026-09-25T03:30:25.323Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00237055" } ] }